325 results on '"Mahler, Donald A."'
Search Results
2. Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD
3. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers
4. Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD
5. Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium
6. Mechanism of Greater Oxygen Desaturation During Walking Compared With Cycling in Patients With COPD
7. Advantages of Endurance Treadmill Walking Compared With Cycling To Assess Bronchodilator Therapy
8. American College of Chest Physicians Consensus Statement on the Management of Dyspnea in Patients With Advanced Lung or Heart Disease
9. Patient-Reported Dyspnea in COPD Reliability and Association With Stage of Disease
10. Prospective Use of Descriptors of Dyspnea to Diagnose Common Respiratory Diseases
11. Recent Advances in Dyspnea
12. Perceptual and Physiologic Responses During Treadmill and Cycle Exercise in Patients With COPD
13. Response
14. One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD
15. Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPD
16. REMOTELY RECORDED PEAK INHALATION FLOW PATTERNS AMONG PATIENTS WITH COPD USING PROAIR DIGIHALER FOR RESCUE MEDICATION
17. Use of Inhaled Corticosteroids in Patients With COPD and the Risk of TB and Influenza: A Systematic Review and Meta-analysis of Randomized Controlled Trials
18. Effect of Increased Blood Levels of β-Endorphin on Perception of Breathlessness
19. Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD
20. Peak Inspiratory Flows
21. Enhanced Drug and Device Development by Targeting “Relief of Dyspnea”
22. Are You Fluent in the Language of Dyspnea?
23. Validity and Responsiveness of the Self-Administered Computerized Versions of the Baseline and Transition Dyspnea Indexes*
24. Pulmonary Rehabilitation*: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines
25. Pulmonary Rehabilitation Executive Summary*: Joint American College of Chest Physicians/American Association of Cardiovascular and Pulmonary Rehabilitation Evidence-Based Clinical Practice Guidelines
26. Responsiveness of Patient-Reported Breathlessness During Exercise in Persistent Asthma*
27. Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD
28. Pulmonary rehabilitation
29. COMPREHENSIVE MEASUREMENT OF BREATHLESSNESS USING THE SELF-ADMINISTERED COMPUTERIZED VERSIONS OF THE BASELINE AND TRANSITION DYSPNEA INDEXES
30. Interleukin-8 Neutralization for COPD
31. Efficacy and Safety of a Monoclonal Antibody Recognizing Interleukin-8 in COPD*: A Pilot Study
32. Comparison of Continuous and Discrete Measurements of Dyspnea During Exercise in Patients With COPD and Normal Subjects*
33. CILOMILAST REDUCES THE PERCENTAGE OF SPUTUM NEUTROPHILS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
34. Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD*
35. Descriptors of Breathlessness in Healthy Individuals*: Distinct and Separable Constructs
36. Do You Speak the Language of Dyspnea?
37. How Should Health-Related Quality of Life Be Assessed in Patients With COPD?*
38. Apples and Oranges: Flaws and Guffaws
39. Efficacy of Salmeterol Xinafoate in the Treatment of COPD*
40. Theoretical Basis for Usefulness of Dyspnea Ratings for Prescription of Exercise in COPD Patients
41. Pulmonary Rehabilitation*
42. Use of the Breathing Reserve To Interpret Submaximal Exercise Responses
43. Dyspnea Ratings for Prescription of Cross-Modal Exercise in Patients With COPD*
44. Salmeterol Reduces Dyspnea and Improves Lung Function in Patients With COPD*
45. Dyspnea Ratings for Prescribing Exercise Intensity in Patients With COPD*
46. Evaluation of the Short-Form 36-Item Questionnaire to Measure Health-Related Quality of Life in Patients With COPD*
47. Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease
48. EFFICACY OF REVEFENACIN BY NEBULIZATION AND TIOTROPIUM BY HANDIHALER IN SUBJECTS WITH COPD AND SUBOPTIMAL PEAK INSPIRATORY FLOW RATES (PIFR)
49. To Improve COPD Care
50. Analysis of Patient Characteristics and Peak Inspiratory Flow Rates in Three Phase 3 Trials of Nebulized Glycopyrrolate in Moderate to Very Severe COPD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.